Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(−)‐hydroxychloroquine ratio | Zendy

Fieger Hiltrud | Zendy; Iredale Joanna | Zendy; Wainer Irving W. | Zendy

Premium

Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(−)‐hydroxychloroquine ratio

Author(s) -

Fieger Hiltrud,

Iredale Joanna,

Wainer Irving W.

Publication year - 1993

Publication title -

chirality

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.43

H-Index - 77

eISSN - 1520-636X

pISSN - 0899-0042

DOI - 10.1002/chir.530050205

Subject(s) - chemistry , hydroxychloroquine , enantiomer , urine , chromatography , enantioselective synthesis , high performance liquid chromatography , pharmacology , stereochemistry , medicine , organic chemistry , biochemistry , catalysis , disease , covid-19 , infectious disease (medical specialty)

A sequential achiral‐chiral high‐performance liquid chromatographic system has been developed for the quantitation in urine of the enantiomers of hydroxychloroquine (HCQ), and of its 3 major metabolites, desethylhydroxychloroquine (DHCQ), desethylchloroquine (DCQ), and bisdesethylchloroquine (BDCQ). HCQ and its metabolites were separated and quantified on a cyano‐bonded phase, and the enantiomeric ratios were determined using a Chiral‐AGP chiral stationary phase. The assay validation and application of this method to a preliminary study in a human volunteer are presented. In this subject, the initial 0‐4 h urine contained the 2 HCQ enantiomers in a ratio of (+)‐HCQ:(−)‐HCQ of 3:2; by the 2,064 h of the study, this ratio had reversed to (+)‐HCQ:(−)‐HCQ of 3:7. © 1993 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research